Shane Bobart, MD, FASN
@ShaneBobart
Followers
1K
Following
5K
Media
31
Statuses
1K
Husband, Father, Son, Nephrologist @MayoClinicNeph Florida. Liverpool FC fan. Tweets = mine and are not medical advice.
Jacksonville, FL
Joined July 2017
RT @MCFNephFellows: Study led by former neph fellow @DrLyleBaker—alongside many of our @MayoClinic Florida neph faculty—explores #kidney ou….
0
5
0
RT @LadanZand: In this multi-center study we describe 3 distinct phenotypes of patients with PLA2R-MN using unsupervised machine learning!….
0
20
0
RT @MayoClinicNeph: Clinical trial at our Mayo Clinic Nephrology: Evaluating daratumumab for treatment of PGNMID (Proliferative Glomerulone….
0
16
0
RT @GFarrugiaMD: At Mayo, we have long recognized AI as a tool to enhance human expertise. @NYTimes takes a closer look at how our differen….
0
15
0
Check out our editorial in @asnpublications #CJASN on an excellent study by @LaurenceHBeckJ1 and team. @fervenzafernan1 @MayoClinicNeph.
Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient? @fervenzafernan1 @ShaneBobart @asnpublications .
0
5
16
Excellent work by @HicksonLKidney @MayoClinicNeph.
Activin A Antagonism with Follistatin Reduces Kidney Fibrosis, Injury, and Cellular Senescence-Associated Inflammation in Murine Diabetic Kidney Disease @HicksonLKidney #MayoClinicKidney
0
0
2
RT @GlomCon: GlomCon is thrilled to introduce a new leadership training opportunity 🤩. The Polycystic Kidney Disease Medical Directorship P….
0
15
0
RT @asnpublications: Follistatin, through activin A antagonism, reduces senescence burden, macrophage infiltration, and proinflammatory pat….
0
5
0
Check out our editorial in @AJKDonline @DrTariqShafi.
@MolnarAmber @LouiseMoist1 @charmaine_lok Editorial by @ShaneBobart and @DrTariqShafi:. To Shower or Not to Shower? Personal Hygiene, Safety, and Patient Choice in Hemodialysis Catheter Care. (FREE)
0
2
16
RT @fouadchebib: Big day — our @JAMA_current review on ADPKD is out today! 📢 Grateful to the JAMA editorial team for their partnership in s….
0
40
0
0
2
13
Our article is out @CleClinicKidney @HMHNephrology @NephroKarger The Clinical and Pathological Characteristics of Patients with Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits.
1
8
35
Thank you @AJKDonline #AJKDBlog for this opportunity once again. Grateful to @yari_nephro and Editor extraordinaire @Khairallah_P @IGANFoundation.
Counting down the Top Ten #AJKDBlog posts of 2024. Drumroll, please!. 1️⃣ Commentary by @yari_nephro and @shanebobart: . IgA Nephropathy, The Hope of Tomorrow, Is Here . (FREE). @Khairallah_P
0
5
14
RT @fervenzafernan1: Time for a new look at how to manage LN. The old proteinuric centric approach is not enough. In patients with anti-ds-….
0
60
0
RT @HMHNephrology: Nephrology fellows and faculty of @HMHNephrology presenting their work @ASNKidney #KidneyWk2024 @HMethodistMD @renuka_to….
0
2
0
RT @mayosingh: @ASNKidney .@MayoClinicNeph . Fun times - Kidney Week 2024.@SuzanneNorby @ShaneBobart @khaledshawwa @SorkkoT .
0
2
0
RT @HMHNephrology: Excellent work by @HMinternalmed Resident Dr. Robert Jameson @ASNKidney #KidneyWk2024 mentored by @HMHNephrology faculty….
0
1
0
Grateful for the collaboration.Kidney Biopsy Findings Among Patients With Diabetes in the Cleveland Clinic Kidney Biopsy Epidemiology Project - Kidney Medicine @alguuuuu @HannySawaf @GildaPortalatin @DrTariqShafi @CleClinicKidney @HMHNephrology @KidneyMed.
0
8
24